Fig. 5. Effects of pharmacological blockage and potentiation of VGSC activity on
galvanotactic responses of MAT-LyLu (A-D) and AT-2 cells (E-H). Data are
plotted as in Fig. 3. The
experimental conditions in the treatments were as follows. (A) MAT-LyLu cells,
1 µM TTX, no electric field. (B) MAT-LyLu, 1 µM TTX (B1) or 5 µM TTX
(B2), electric field of 3 V cm-1. (C) MAT-LyLu cells, 10 µM
veratridine, no electric field. (D) MAT-LyLu cells, 10 µM veratridine,
electric field of 3 V cm-1. (E) AT-2, 1 µM TTX, no electric
field. (F) AT-2, 1 µM TTX, electric field of 3 V cm-1. (G) AT-2,
10 µM veratridine, no electric field. (H) AT-2, 10 µM veratridine,
electric field of 3 V cm-1.
